Across
- 3. test used to screen for LOPS in sensory neuropathy
- 4. includes CVD, stroke, & PVD
- 5. plasma glucose level diagnostic when > 200 mg/dL or higher w/SxS hyperglycemia
- 7. main cause of DM1
- 8. hyperglycemia in the morning caused by insufficient insulin to counteract early morning hormone surges
- 11. hyperglycemic ________ syndrome presents with severe hyperglycemia, severe dehydration, & electrolyte disturbances
- 13. rapid-acting insulin, onset 10-15 mins, peak 0.5-3H, duration 3-5H
- 14. produced with insulin when enzymes split proinsulin, used to monitor pancreatic beta-cell function
- 21. drug class that commonly causes hyperglycemia
- 24. portion of pancreas that produces insulin
- 25. avoid nephrotoxic drugs, monitor protein intake, prevent UTIs, treat HTN
- 27. increased appetite/eating
- 28. plasma glucose level diagnostic when > 126 mg/dL
- 29. primary feature of DM2 in regards to insulin sensitivity
- 31. yellowish hue to skin, can be sign of hepatotoxicity
- 34. short-acting insulin, only type that can be given IV
- 35. type of DM that lacks endogenous insulin
- 36. type of insulin that can NOT be mixed with other insulins
- 40. diabetic ________ presents with hyperglycemia, dehydration, ketosis, & acidosis
- 42. type of pressure that glucose exerts on the fluid around it, drawing fluids close
- 44. hormone produced by pancreas, used in glucose metabolism
Down
- 1. type of DM with insulin resistance & insulin use insufficiency
- 2. hyperglycemia in the morning due to excessive insulin or counter-regulatory response to overnight hypoglycemia
- 4. biguanide drug, no risk for hypoglycemia; major risk for lactic acidosis during acute illness
- 6. specific to DM, common of eyes & kidneys
- 9. describes onset of DM2
- 10. supplies of this are replenished by eating complex carbs after hypoglycemic episode
- 11. elevated blood glucose
- 12. chronic multisystem disease with marked hyperglycemia
- 15. increased thirst/drinking
- 16. rapid-acting insulin, onset 10-15 mins, take 10-15 mins before meal; ^risk for hypoglycemia
- 17. alpha-glucosidase inhibitor, commonly causes GI side effects
- 18. clear before _____ insulin when mixing in same syringe
- 19. form of autonomic neuropathy of stomach, treated with prokinetic agents & lifestyle changes
- 20. NPH is this type of insulin; its cloudy, onset 1-2H, peak 4-14H, duration 14-24H
- 22. describes onset of DM1
- 23. reflects past 2-3 months of plasma glucose levels, goal <6.5% for non-DM
- 24. type of PO drug that needs to be held 48H prior to IV contrast, can resume 48H post-procedure if kidneys ok
- 26. when protein "spills" into urine, checked for nephropathy diagnosis
- 30. type of syndrome with increased waist circumference, low HDL, high BP, high fasting BG, & high triglycerides
- 32. when this electrolyte is low, cardiac dysrhythmias are common
- 33. sulfonylurea drug, stimulates pancreatic insulin production/release; risk of hypoglycemia
- 37. when ingested, insulin promotes their use and storage
- 38. present @ time of DM1 diagnosis
- 39. type of respirations common with DKA, aids in blowing off CO2 to raise pH
- 41. condition when BG < 70 mg/dl; presents with shakiness, tremors, tachycardia
- 43. frequent urination, considered a cardinal sign of DM